Gemcitabine-Induced Acute Coronary Syndrome: A Case Report

被引:11
作者
Ozturk, Banu [1 ]
Tacoy, Gulten [2 ]
Coskun, Ugur [1 ]
Yaman, Emel [1 ]
Sahin, Giray [1 ]
Buyukberber, Suleyman [1 ]
Yildiz, Ramazan [1 ]
Kaya, Ali O. [1 ]
Topal, Salih [2 ]
Ozdemir, Murat [2 ]
Benekli, Mustafa [1 ]
机构
[1] Gazi Univ, Sch Med, Dept Med Oncol, TR-06500 Ankara, Turkey
[2] Gazi Univ, Sch Med, Dept Cardiol, TR-06500 Ankara, Turkey
关键词
Gemcitabine; Coronary syndrome; Left bundle-branch block; ACUTE MYOCARDIAL-INFARCTION; PHASE-II; 5-FLUOROURACIL; THERAPY; CANCER;
D O I
10.1159/000163051
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Objectives: To report a case of metastatic leiomyosarcoma, in which a patient developed chest pain accompanied by acute left bundle-branch block (LBBB) after gemcitabine infusion. Clinical Presentation and Intervention: A 59-year-old woman admitted with bilateral pulmonary nodules had classic risk factors for coronary heart disease and coronary stenosis as demonstrated by previous coronary angiography. She was treated with gemcitabine infusion, and 30 min later she experienced severe chest pain accompanied by acute LBBB confirmed by ECG. We suspected gemcitabine-induced coronary vasospasm exacerbated by the preexisting coronary artery disease as the cause of the acute coronary syndrome. The patient was subsequently treated with antianginal therapy and percutaneous coronary intervention. Her chest pain resolved and LBBB disappeared. She was discharged 2 days later without any further cardiac events. No additional cancer therapy was given and she died 5 months later, due to disease progression. Conclusion: This case showed that chemotherapeutic agents must be administered with intensive cardiac monitoring especially in patients with cardiac disease and well-known risk factors to prevent the development of cardiac complications, despite an agent not being known to be 'cardiotoxic'. Copyright (C) 2008 S. Karger AG, Basel
引用
收藏
页码:76 / 80
页数:5
相关论文
共 12 条
[1]  
Abbratt RP, 1994, J CLIN ONCOL, V12, P1535
[2]   Gemcitabine and acute myocardial infarction - A case report [J].
Bdair, Fadi M. ;
Graham, Susan P. ;
Smith, Patrick F. ;
Javle, Milind M. .
ANGIOLOGY, 2006, 57 (03) :367-371
[3]   A case of acute myocardial infarction during 5-fluorouracil infusion [J].
Canale, Maria Laura ;
Camerini, Andrea ;
Stroppa, Stefano ;
Porta, Rornana Prosperi ;
Caravelli, Paolo ;
Mariani, Mario ;
Balbarini, Alberto ;
Ricci, Sergio .
JOURNAL OF CARDIOVASCULAR MEDICINE, 2006, 7 (11) :835-837
[4]   Phase II study of gemcitabine in patients with advanced pancreatic cancer [J].
Carmichael, J ;
Fink, U ;
Russell, RCG ;
Spittle, MF ;
Harris, AL ;
Spiessi, G ;
Blatter, J .
BRITISH JOURNAL OF CANCER, 1996, 73 (01) :101-105
[5]  
Coskun U, 2004, CASE REP PRACT REV, V5, P178
[6]   Gemcitabine as a single agent in the treatment of relapsed or refractory low-grade non-Hodgkin's lymphoma [J].
Dumontet, C ;
Morschhauser, F ;
Solal-Celigny, P ;
Bouafia, F ;
Bourgeois, E ;
Thieblemont, C ;
Leleu, X ;
Hequet, O ;
Salles, G ;
Coiffier, B .
BRITISH JOURNAL OF HAEMATOLOGY, 2001, 113 (03) :772-778
[7]   An open label, non-comparative phase II study of gemcitabine as salvage treatment for patients with pretreated adult type soft tissue sarcoma [J].
Hartmann, JT ;
Oechsle, K ;
Huober, J ;
Jakob, A ;
Azemar, M ;
Horger, M ;
Kanz, L ;
Bokemeyer, C .
INVESTIGATIONAL NEW DRUGS, 2006, 24 (03) :249-253
[8]   Acute myocardial infarction following gemcitabine therapy - A case report [J].
Kalapura, T ;
Krishnamurthy, M ;
Reddy, CV .
ANGIOLOGY, 1999, 50 (12) :1021-1025
[9]   CARDIAC TOXICITY OF 5-FLUOROURACIL - A STUDY ON 1083 PATIENTS [J].
LABIANCA, R ;
BERETTA, G ;
CLERICI, M ;
FRASCHINI, P ;
LUPORINI, G .
TUMORI, 1982, 68 (06) :505-510
[10]   Cardiotoxicity of chemotherapeutic agents - Incidence, treatment and prevention [J].
Pai, VB ;
Nahata, MC .
DRUG SAFETY, 2000, 22 (04) :263-302